Curie.Bio website screenshot

Curie.Bio

Curie.Bio is a seed-stage biotech venture firm and drug-discovery co-pilot co-founded by Zach Weinberg (founder of Flatiron Health), Alexis Borisy, and Christoph Lengauer. It pairs seed investment — typically $5M-$7M initial checks, backed by a $380M pro-rata Series A follow-on fund — with hands-on scientific and operational support from a team of experienced drug hunters, helping therapeutics founders design their science and move programs into the clinic and toward a strong next round of financing. Curie.Bio has raised close to $1B and is backed by GV, a16z, and ARCH Venture Partners. It operates as a company/investor profile in the API Evangelist network; it publishes no public developer API or platform, so most technical API artifacts are not applicable to this provider.

Curie.Bio is profiled on the APIs.io network. Tagged areas include Company, Venture Capital, Biotechnology, Life Sciences, and Drug Discovery.

Curie.Bio’s developer surface includes support and 8 more developer resources.

14.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyVenture CapitalBiotechnologyLife SciencesDrug DiscoveryTherapeuticsSeed InvestmentAccelerator

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.6/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.9 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/curiebio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Curiebio Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Documentation 1

Reference material describing how the API behaves

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 4

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: curiebio
name: Curie.Bio
description: Curie.Bio is a seed-stage biotech venture firm and drug-discovery co-pilot co-founded by Zach Weinberg (founder
  of Flatiron Health), Alexis Borisy, and Christoph Lengauer. It pairs seed investment — typically $5M-$7M initial checks,
  backed by a $380M pro-rata Series A follow-on fund — with hands-on scientific and operational support from a team of experienced
  drug hunters, helping therapeutics founders design their science and move programs into the clinic and toward a strong next
  round of financing. Curie.Bio has raised close to $1B and is backed by GV, a16z, and ARCH Venture Partners. It operates
  as a company/investor profile in the API Evangelist network; it publishes no public developer API or platform, so most technical
  API artifacts are not applicable to this provider.
url: https://raw.githubusercontent.com/api-evangelist/curiebio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- gv
x-tier: profiled
x-tier-reason: enriched-identity-no-public-api
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://curie.bio/wp-content/uploads/2023/01/logo-curiebio.png
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Venture Capital
- Biotechnology
- Life Sciences
- Drug Discovery
- Therapeutics
- Seed Investment
- Accelerator
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/curiebio-domain-security.yml
- type: Website
  url: https://curie.bio/
- type: About
  url: https://curie.bio/our-team/
- type: Support
  url: https://curie.bio/contact-us/
- type: Careers
  url: https://curie.bio/careers/
- type: FounderGuide
  url: https://curie.bio/founder-guide/
- type: TermsOfService
  url: https://curie.bio/terms-of-use
- type: PrivacyPolicy
  url: https://curie.bio/privacy-policy
- type: LinkedIn
  url: https://www.linkedin.com/company/curie-bio
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence